These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3917674)

  • 1. Oral labetalol in the management of stable angina pectoris in normotensive patients.
    Upward JW; Akhras F; Jackson G
    Br Heart J; 1985 Jan; 53(1):53-7. PubMed ID: 3917674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of combined alpha and beta adrenoceptor blockade in patients with angina pectoris. A double blind study comparing labetalol with placebo.
    Quyyumi AA; Wright C; Mockus L; Shackell M; Sutton GC; Fox KM
    Br Heart J; 1985 Jan; 53(1):47-52. PubMed ID: 3881105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind trial comparing labetalol with atenolol in the treatment of systemic hypertension with angina pectoris.
    Jee LD; Opie LH
    Am J Cardiol; 1985 Sep; 56(8):551-4. PubMed ID: 3929584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Labetalol in the treatment of stable exertional angina pectoris: a comparison with nifedipine.
    Crake T; Mulcahy D; Wright C; Fox K
    Eur Heart J; 1988 Nov; 9(11):1200-5. PubMed ID: 3069466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of labetalol on the exercise tolerance test in patients with angina pectoris].
    Cherchi A; Fonzo R; Lai C; Mercuro G
    Boll Soc Ital Cardiol; 1978; 23(1):281-97. PubMed ID: 113022
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomised, double-blind, three-way cross-over study of dilevalol 200 and 400 mg and atenolol 100 mg once-daily in patients with chronic stable angina pectoris.
    Bowles MJ; Smith L; Glover DR
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():85-90. PubMed ID: 2196372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effect of labetalol in hypertensive patients with angina pectoris.
    Lubbe WF; White DA
    S Afr Med J; 1983 Jan; 63(3):67-71. PubMed ID: 6849167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Labetalol compared with propranolol in patients with both angina pectoris and systemic hypertension: a double-blind study.
    Frishman WH; Shapiro W; Charlap S
    J Clin Pharmacol; 1989 Jun; 29(6):504-11. PubMed ID: 2666451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Trial of labetalol in effort angina pectoris].
    Broustet JP; Cherrier JF; Pic A
    Ann Cardiol Angeiol (Paris); 1985 Mar; 34(3):171-6. PubMed ID: 4004091
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part II. Effects of oral labetalol in patients with both angina pectoris and hypertension: a preliminary experience.
    Halprin S; Frishman W; Kirschner M; Strom J
    Am Heart J; 1980 Mar; 99(3):388-96. PubMed ID: 7355700
    [No Abstract]   [Full Text] [Related]  

  • 11. Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patients.
    Besterman EM; Spencer M
    Br J Clin Pharmacol; 1979; 8(Suppl 2):205S-209S. PubMed ID: 526402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternatives to beta-blockade in therapy of hypertension with angina pectoris: role of nifedipine or of labetalol.
    Opie LH; White D; Lee J; Lubbe WF
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):115S-122S. PubMed ID: 7093094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sotalol in angina pectoris. A double-blind study.
    Slome R
    S Afr Med J; 1976 Mar; 50(12):469-72. PubMed ID: 818720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Labetalol in hypertensive patients with angina pectoris: beneficial effect of combined alpha- and beta-adrenoreceptor blockade.
    Lubbe WF; White DA
    Clin Sci Mol Med Suppl; 1978 Dec; 4():283s-286s. PubMed ID: 32006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic and coronary hemodynamic effects of combined oral alpha- and beta-adrenergic blockade (labetalol) in normotensive patients with stable angina pectoris and positive exercise stress tests.
    Feldman RL; Prida XE; Hill JA
    Clin Cardiol; 1988 Jun; 11(6):383-8. PubMed ID: 3396239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Labetalol in normotensive patients with angina pectoris.
    Fox K; Quyyumi AA
    Cardiovasc Drugs Ther; 1988 Sep; 2(3):363-7. PubMed ID: 3154918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of dilevalol in patients with chronic stable angina pectoris.
    Glasser SP; Bittar N; Kinhal V; Bennett WT; Koehn DK
    J Clin Pharmacol; 1989 Nov; 29(11):983-8. PubMed ID: 2574729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained effects of transdermal nitroglycerin in patients with angina pectoris.
    Kapoor AS; Dang NS; Reynolds RD
    Clin Ther; 1985; 7(6):674-9. PubMed ID: 3935313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atenolol: once-daily cardioselective beta blockade for angina pectoris.
    Jackson G; Schwartz J; Kates RE; Winchester M; Harrison DC
    Circulation; 1980 Mar; 61(3):555-60. PubMed ID: 6243518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.